Dengue and falciparum malaria co-infection in travelers returning from Burkina Faso: Report of two cases in Northeastern Italy

Abstract

Rationale: Malaria and dengue are the most prevalent vector-borne diseases in tropical countries. Plasmodium parasite and dengue virus (DENV) concurrent infection is possible and often under-recognized in geographical areas where these infections are both endemic. Patients concern and diagnosis: We describe the first two cases of Plasmodium falciparum and DENV-3 co-infection in travelers returning to northeastern Italy from Burkina Faso during 2013-2014. Interventions: Malaria infection in both patients was treated with mefloquine. Due to the persistence of symptoms despite of the antimalaria treatment, dengue was also investigated; the treatment of dengue was symptomatic. Outcomes: The patients were discharged in good general condition. Lessons: The need for surveillance of potential malaria and dengue co-infection in travelers returning to Europe from endemic areas is highlighted, as infection with Plasmodium does not exclude arboviral co-infection.

Keywords

Dengue virus / Falciparum malaria / Travelers infection / Co-infection / Arbovirus

References

[1] World Health Organization. World malaria report 2022. Geneva: World Health Organization ; 2022.

[2] World Health Organization. Dengue and severe dengue. [Online]. Available from:https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue. [Accessed on 19 December 2022].

[3] Leder K, Torresi J, Libman MD, Cramer JP, Castelli F, Schlagenhauf P, et al. GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med 2013; 158(6):456-468.

[4] Pierro A, Landini MP, Gaibani P, Rossini G, Vocale C, Finarelli AC, et al. A model of laboratory surveillance for neuro-arbovirosis applied during 2012 in the Emilia-Romagna region, Italy. Clin Microbiol Infect 2014; 20(7):672-677.

[5] Tarnagda Z, Congo M, Sagna T, Ouédraogo C, Niki V, Cissé A, et al. Outbreak of dengue fever in Ougadougou, Burkina Faso, 2013. Int J Microbiol Immunol Res 2014; 2(7):101-108.

[6] Stoler J, Al Dashti R, Anto F, Fobil JN, Awandare GA. Deconstructing "malaria": West Africa as the next front for dengue fever surveillance and control. Acta Trop 2014; 134:58-65.

[7] Kotepui M, Kotepui KU, Milanez GJ, Masangkay FR. Prevalence of and risk factors for severe malaria caused by Plasmodium and dengue virus co-infection: A systematic review and meta-analysis. Infect Dis Poverty 2020; 9(1):134.

[8] World Health Organization. Dengue: Guidelines for diagnosis, treatment, prevention and control. [Online]. Available from:https://apps.who.int/iris/handle/10665/44188. [Accessed on 15 January 2022].

[9] Donati D, Zhang LP, Chêne A, Chen O, Flick K, Nyström M, et al. Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect Immun 2004; 72(9):5412-5418.

[10] European Center for Disease Control. Autochthonous transmission of dengue virus in mainland EU/EEA, 2010-present. [Online]. Available from:https://www.ecdc.europa.eu/en/all-topics-z/dengue/surveillance-and-disease-data/autochthonous-transmission-dengue-virus-eueea. [Accessed on 19 December 2022].